Sorry, this will be the last Lazy Linking for the day... Ben Goldacre really knows what he's talking about. On his blog (
BadScience) and his
Guardian column, Goldacre regularly and authoritatively talks up evidence-based medicine and takes apart pseudoscience and medical myths. So I wasn't surprised that Goldacre expertly puts the
much publicized recent study on the effectiveness of SSRI antidepressants into perspective. In his
latest column entry, he argues, persuasively, that the importance of the study's findings pale in comparison to the importance of sorting out the problem at the root of what has transpired: our failure to regulate the pharmaceutical industry adequately. Specifically, the need to combat publication bias by creating a
compulsory international medical trails register.
Read, agree and
support open access!
No comments:
Post a Comment